Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.545
-0.125 (-2.68%)
Sep 10, 2026, 10:46 AM EDT - Market open

Foghorn Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
68.0880.8855.4580.3452.21101.14
Short-Term Investments
99.578.02188.29153.72293.5853.15
Cash & Short-Term Investments
167.58158.89243.75234.06345.8154.29
Cash Growth
-15.65%-34.81%4.14%-32.31%124.12%-16.95%
Receivables
-----300
Prepaid Expenses
2.463.095.856.125.65.27
Restricted Cash
-1.25----
Total Current Assets
170.05163.24249.6240.18351.4459.56
Property, Plant & Equipment
31.3432.8632.6142.9149.456.08
Other Long-Term Assets
221.782.824.094.13
Total Assets
203.39198.1283.98285.92404.88519.77

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.214.273.796.265.413.82
Accrued Expenses
7.9611.368.538.43119.56
Current Portion of Leases
2.820.929.078.525.976.99
Current Income Taxes Payable
---0.67--
Current Unearned Revenue
36.5943.1945.6134.5532.8228.32
Total Current Liabilities
50.5859.7466.9958.4455.2148.69
Long-Term Leases
40.2840.3528.0636.5645.5451.34
Long-Term Unearned Revenue
193.22205.96234.46268.12304322.73
Other Long-Term Liabilities
0.350.56--0.030.14
Total Liabilities
284.43306.6329.51363.11404.77422.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01000
Additional Paid-In Capital
578.62523.94512.52395.2377.23361.13
Retained Earnings
-659.53-632.47-558.18-471.56-373.14-264.26
Comprehensive Income & Other
-0.130.020.14-0.83-3.99-0.01
Total Common Equity
-81.04-108.5-45.53-77.190.1196.87
Shareholders' Equity
-81.04-108.5-45.53-77.190.1196.87
Total Liabilities & Equity
203.39198.1283.98285.92404.88519.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
43.141.2737.1345.0751.5158.33
Net Cash (Debt)
124.48117.62206.62188.98294.2995.96
Net Cash Growth
-28.85%-43.07%9.33%-35.78%206.69%-7.53%
Net Cash Per Share
1.871.873.764.507.082.58
Filing Date Shares Outstanding
59.3958.755.6142.5741.841.42
Total Common Shares Outstanding
58.7156.6655.5942.2841.841.3
Working Capital
119.47103.5182.61181.75296.19410.87
Book Value Per Share
-1.38-1.92-0.82-1.830.002.35
Tangible Book Value
-81.04-108.5-45.53-77.190.1196.87
Tangible Book Value Per Share
-1.38-1.92-0.82-1.830.002.35
Machinery
8.978.928.037.736.85.8
Leasehold Improvements
--17.0217.2417.1217.06
SEC Filings: 10-K · 10-Q